Congress Scrutinizes FDA’s Role in CBD Regulation

Congress Scrutinizes FDA’s Role in CBD Regulation

Jonathan Miller, general counsel at the U.S. Hemp Roundtable represented hemp stakeholders at a congressional hearing last week to determine if the U.S. Food and Drug Administration (FDA) had failed to meet its charter obligations by not moving to regulate CBD.

The FDA has

Membership required to view content.
that it does not have the authority to regulate CBD, nor is there an existing regulatory framework for cannabinoids, they argue.  FDA is reluctant to wade into cannabis.  It is a complicated subject, with overlapping agency interests, and many decades of entrenched policy that makes the issue radioactive for…

Membership is required to view the rest of this post.
Click here to learn more and sign up for a free 7-day trial!

Blog

11.21.2024

Domestic US biodiesel blending helps lift October RFS RIN production

Domestic US biodiesel blending helps lift October RFS RIN production

US domestic biodiesel blending of 147.5 million gallons in October produced a monthly high of 221.2 million renewable identification number (RIN) credits for January-October. This was 11.5% above September...

11.21.2024

CWG trades lower as broader animal fats markets hold steady

CWG trades lower as broader animal fats markets hold steady

The US animal fats and oils markets held steady on Thursday November 21, with limited trading as attention shifted toward broader macroeconomic factors and...

11.21.2024

October commercial cattle, hog production above 2023

October commercial cattle, hog production above 2023

US animal protein prices were steady on Thursday November 21. Limited trade was reported from market sources due to the proximity of the extended Thanksgiving holiday weekend in the...

Latest Tweets